title: Sildenafil stimulates aqueous humor turnover in rabbits.
abstract: Sildenafil citrate increases ocular blood flow and accelerates the rate of anterior chamber refilling after paracentesis. The latter effect could have resulted from a reduction in outflow facility or from an increase in aqueous humor (AH) production. In this study, we used scanning ocular fluorophotometry to examine the effects of sildenafil on AH turnover, and thus, AH production in eyes of live normal rabbits. For this, the rate of aqueous humor flow (AHF) was quantified with a commercially available fluorophotometer that measured the rate of fluorescein clearance from the anterior segment, which predominantly occurs via the trabecular meshwork. After ≈2 h of control scans to determine the baseline rate of AHF, the rabbits were fed 33 mg of sildenafil and allowed ≈45 min for the drug to enter the systemic circulation. Thereafter, fluorescence scans were retaken for an additional 90-120 min. Sildenafil ingestion increased AHF by about 36%, from 2.31 μL/min to 3.14 μL/min (P < 0.001, as two-tailed paired data, n = 20 eyes). This observation indicates that sildenafil citrate, which is a phosphodiesterase type-5 inhibitor currently marketed as a vasodilator (e.g., Viagra, Revatio), stimulates AHF in rabbits. Our results seem consistent with reports indicating that the drug dilates intraocular arteries and augments intraocular vascular flow. These physiological responses to the agent apparently led to increased fluid entry into the anterior chamber. As such, the drug might have utility in patients with ocular hypotony resulting from insufficient AH formation.
authors.affiliation: Department of Ophthalmology, Mount Sinai School of Medicine, Box 1183, Fifth Avenue and 100th Street, New York, NY 10029, USA.
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Alvarez
authors.forename: Aldo C
authors.initials: AC
authors.lastname: Zamudio
authors.forename: Oscar A
authors.initials: OA
authors.lastname: Candia
mesh_terms: D000818:Animals; D000867:Anterior Chamber / Q000098:blood supply / Q000378:metabolism; D001082:Aqueous Humor / Q000187:drug effects* / Q000378:metabolism*; D002924:Ciliary Body / Q000098:blood supply / Q000378:metabolism; D015590:Fluorophotometry; D058986:Phosphodiesterase 5 Inhibitors / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011687:Purines / Q000494:pharmacology; D011817:Rabbits; D012039:Regional Blood Flow / Q000187:drug effects; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000494:pharmacology*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate
references.citation: Curr Pharm Des. 2009;15(30):3540-51
references.pmid: 19860699
references.citation: Br J Ophthalmol. 2008 Apr;92(4):469-73
references.pmid: 18369062
references.citation: Physiol Rev. 1975 Jul;55(3):383-417
references.pmid: 1153528
references.citation: Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3139-44
references.pmid: 20089876
references.citation: Am J Cardiol. 1999 Mar 4;83(5A):13C-20C
references.pmid: 10078538
references.citation: Trans Am Ophthalmol Soc. 1999;97:115-25; discussion 125-8
references.pmid: 10703120
references.citation: Invest Ophthalmol Vis Sci. 2012 Feb 01;53(2):565-73
references.pmid: 22205610
references.citation: Exp Eye Res. 1966 Jul;5(3):208-20
references.pmid: 5914653
references.citation: Prog Retin Eye Res. 2002 Sep;21(5):485-506
references.pmid: 12207947
references.citation: Compr Ophthalmol Update. 2007 Jan-Feb;8(1):29-37
references.pmid: 17394757
references.citation: Invest Ophthalmol Vis Sci. 1985 Feb;26(2):144-52
references.pmid: 3972497
references.citation: Exp Eye Res. 2011 Jul;93(1):103-7
references.pmid: 21651908
references.citation: Surv Ophthalmol. 1999 Sep-Oct;44(2):153-62
references.pmid: 10541153
references.citation: Acta Ophthalmol Scand. 2005 Jun;83(3):355-9
references.pmid: 15948790